QuantumPharm is a Hong Kong-based quantum technology company founded in 2015 by three MIT-trained quantum physicists. It focuses on drug discovery and materials R&D by combining quantum physics, artificial intelligence, cloud computing, and robotics. The company applies quantum-enhanced computational methods to accelerate pharmaceutical development, biotechnology research, renewable energy solutions, and advanced materials discovery.
QuantumPharm completed an IPO on the Hong Kong Stock Exchange with a strong trading debut, becoming one of the few publicly traded quantum-focused companies in Asia. It serves pharmaceutical companies, biotech firms, and materials science organizations seeking to use quantum computing for molecular simulation and discovery.
Quantum Specifications
Quantum Focus
hardware
Backed By
Lakestar
Lightspeed Venture Partners
Quantum Coast Capital
Type One Ventures
Trumpf Venture
Gic Government Of Singapore Investment Corporation
Hercules Capital
Inven Capital
Application Areas
PharmaceuticalsBiotechnologyMaterials scienceRenewable energy
Frequently Asked Questions
QuantumPharm is a Hong Kong-based quantum technology company founded in 2015 by three MIT-trained quantum physicists. It focuses on drug discovery and materials R&D by combining quantum physics, artificial intelligence, cloud computing, and robotics. The company applies quantum-enhanced computational methods to accelerate pharmaceutical development, biotechnology research, renewable energy solutions, and advanced materials discovery.
QuantumPharm completed an IPO on the Hong Kong Stock Excha...
QuantumPharm is headquartered in Hong Kong, Hong Kong.
QuantumPharm was founded in 2015.
Yes, QuantumPharm is publicly traded under the ticker symbol 2228 on the HKEX.
QuantumPharm operates in the following sectors: quantum software, quantum pharma, quantum machine learning, quantum materials.
